Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to "potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases".

Talotta, Rossella

Talotta, Rossella.

Talotta R; Department of Clinical and Experimental Medicine, Rheumatology Unit, University of Messina, University Hospital "G. Martino", Messina, Italy. Electronic address: talotta1@virgilio.it.

Clin Immunol ; 224: 108665, 2021 03.

Article in English | MEDLINE | ID: covidwho-1018977

Subject(s)

Autoimmune Diseases; COVID-19; COVID-19 Vaccines; Humans; RNA; SARS-CoV-2

Keywords

Autoimmunity; Autoinflammation; COVID-19; Immune response; SARS-CoV-2; Type I interferon; mRNA vaccine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Autoimmune Diseases / COVID-19 Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Clin Immunol Journal subject: Allergy and Immunology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google